Renaissance Technologies's LLY Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 165,847 shares of Eli Lilly and Company (LLY) worth $178.23 M, representing 0.28% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Renaissance Technologies has maintained a long-term strategic position in LLY, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2017, adding 2.71 M shares. Largest reduction occurred in Q3 2013, reducing 4.04 M shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's Eli Lilly and Company (LLY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Eli Lilly and Company (LLY) Trades by Renaissance Technologies
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +12.33 M | Add 0.00% | 12.33 M | $49.12 |
| Q3 2013 | -4.04 M | Reduce 32.76% | 8.29 M | $50.33 |
| Q4 2013 | -1.23 M | Reduce 14.79% | 7.06 M | $51.00 |
| Q1 2014 | -1.81 M | Reduce 25.57% | 5.26 M | $58.86 |
| Q2 2014 | -1.91 M | Reduce 36.42% | 3.34 M | $62.17 |
| Q3 2014 | -1.58 M | Reduce 47.22% | 1.76 M | $64.85 |
| Q4 2014 | -940,700 | Reduce 53.33% | 823,200 | $68.99 |
| Q1 2015 | -404,395 | Reduce 49.12% | 418,805 | $72.65 |
| Q2 2015 | -418,805 | Sold Out | 0 | $0.00 |
| Q3 2015 | +221,005 | New Buy | 221,005 | $83.69 |
| Q4 2015 | +111,800 | Add 50.59% | 332,805 | $84.26 |
| Q1 2016 | +1.88 M | Add 565.14% | 2.21 M | $72.01 |
| Q2 2016 | -22,400 | Reduce 1.01% | 2.19 M | $78.75 |
| Q3 2016 | -1.27 M | Reduce 57.91% | 922,200 | $80.26 |
| Q4 2016 | +617,000 | Add 66.91% | 1.54 M | $73.55 |
| Q1 2017 | +1.44 M | Add 93.63% | 2.98 M | $84.11 |
| Q2 2017 | +2.71 M | Add 91.08% | 5.69 M | $82.30 |
| Q3 2017 | -1.65 M | Reduce 28.90% | 4.05 M | $85.54 |
| Q4 2017 | +222,900 | Add 5.50% | 4.27 M | $84.46 |
| Q1 2018 | -516,400 | Reduce 12.09% | 3.76 M | $77.37 |
| Q2 2018 | -3.27 M | Reduce 87.01% | 488,000 | $85.33 |
| Q3 2018 | -488,000 | Sold Out | 0 | $0.00 |
| Q4 2018 | +10,800 | New Buy | 10,800 | $115.74 |
| Q1 2019 | +713,854 | Add 6609.76% | 724,654 | $129.76 |
| Q2 2019 | +1.58 M | Add 218.58% | 2.31 M | $110.79 |
| Q3 2019 | -2.15 M | Reduce 92.95% | 162,699 | $111.83 |
| Q4 2019 | -162,699 | Sold Out | 0 | $0.00 |
| Q1 2020 | +214,600 | New Buy | 214,600 | $138.72 |
| Q2 2020 | +399,347 | Add 186.09% | 613,947 | $164.18 |
| Q3 2020 | -132,400 | Reduce 21.57% | 481,547 | $148.02 |
| Q4 2020 | -481,547 | Sold Out | 0 | $0.00 |
| Q1 2021 | +232,947 | New Buy | 232,947 | $186.82 |
| Q2 2021 | -146,847 | Reduce 63.04% | 86,100 | $229.52 |
| Q3 2021 | +967,347 | Add 1123.52% | 1.05 M | $231.05 |
| Q4 2021 | -859,500 | Reduce 81.59% | 193,947 | $276.22 |
| Q1 2022 | -90,247 | Reduce 46.53% | 103,700 | $286.37 |
| Q2 2022 | +297,183 | Add 286.58% | 400,883 | $324.23 |
| Q3 2022 | +613,764 | Add 153.10% | 1.01 M | $323.35 |
| Q4 2022 | -241,293 | Reduce 23.78% | 773,354 | $0.37 |
| Q1 2023 | -319,774 | Reduce 41.35% | 453,580 | $0.34 |
| Q2 2023 | -440,571 | Reduce 97.13% | 13,009 | $0.47 |
| Q3 2023 | +122,455 | Add 941.31% | 135,464 | $537.13 |
| Q4 2023 | +138,399 | Add 102.17% | 273,863 | $582.92 |
| Q1 2024 | -143,685 | Reduce 52.47% | 130,178 | $777.97 |
| Q2 2024 | -130,178 | Sold Out | 0 | $0.00 |
| Q3 2024 | +257,813 | New Buy | 257,813 | $885.94 |
| Q4 2024 | -203,693 | Reduce 79.01% | 54,120 | $772.02 |
| Q1 2025 | +42,192 | Add 77.96% | 96,312 | $825.92 |
| Q2 2025 | -96,051 | Reduce 99.73% | 261 | $784.15 |
| Q3 2025 | -261 | Sold Out | 0 | $0.00 |
| Q4 2025 | +165,847 | New Buy | 165,847 | $1074.68 |
Renaissance Technologies's Eli Lilly and Company Investment FAQs
Renaissance Technologies first purchased Eli Lilly and Company (LLY) in Q2 2013, acquiring 12,326,205 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held Eli Lilly and Company (LLY) for 51 quarters since Q2 2013.
Renaissance Technologies's largest addition to Eli Lilly and Company (LLY) was in Q2 2013, adding 12,326,205 shares worth $605.46 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 165,847 shares of Eli Lilly and Company (LLY), valued at approximately $178.23 M.
As of the Q4 2025 filing, Eli Lilly and Company (LLY) represents approximately 0.28% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies's peak holding in Eli Lilly and Company (LLY) was 12,326,205 shares, as reported at the end of Q2 2013.